Brownell, N. and Kumtornrut, C. 2017. Cutaneous hyperpigmentation induced by daclatasvir, sofosbuvir, and ribavirin combination therapy. Thai Journal of Dermatology. 33, 2 (Jun. 2017), 173–179.